Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07040280 · ClinicalTrials.gov registry record · Phase 2
Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Not yet
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
NCT07040280 is a Phase 2 study that has not yet begun recruiting, run by Eastern Cooperative Oncology Group. The registered enrollment target is 120 participants.
The verdict
NCT07040280, a Phase 2 study, has not yet begun recruiting, sponsored by Eastern Cooperative Oncology Group.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the safety and effects of sulforaphane with the safety and effects of placebo on people's risk of developing melanoma. The main question it aims to answer is: Will giving sulforaphane (a broccoli sprout extract) have a meaningful effect on how your atypical moles change over time? If there is an effect, will this lower your risk of developing melanoma? Participants will: Take sulforaphane or a placebo for 12 months Visit the clinic once every 3 months for checkups and tests You will keep a calendar which will help you keep track of when you take your tablets
Interventions
- DRUG Placebo
- DRUG Sulforaphane (broccoli sprout extract)
- DEVICE Derma-AI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-10-31 |
| Est. Completion | 2029-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07040280
The ClinicalTrials.gov registry entry for NCT07040280 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Cooperative Oncology Group, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07040280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07040280 about?
NCT07040280 is a clinical study titled "Testing the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of Melanoma". The goal of this clinical trial is to compare the safety and effects of sulforaphane with the safety and effects of placebo on people's risk of developing melanoma. The main question it aims to answer is: Will giving sulforaphane (a broccoli sprout extract) have a meaningful effect on how your atyp...
What is the current status of trial NCT07040280?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-10-31. Estimated completion is 2029-08-01.
What interventions are being tested in trial NCT07040280?
The interventions under investigation include: Placebo (DRUG), Sulforaphane (broccoli sprout extract) (DRUG), Derma-AI (DEVICE).
Who is sponsoring clinical trial NCT07040280?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.